Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.140
-0.060 (-1.88%)
Feb 11, 2026, 4:36 PM CET
Arterra Bioscience Revenue
In the year 2024, Arterra Bioscience had annual revenue of 4.17M EUR with 25.08% growth. Arterra Bioscience had revenue of 1.61M in the half year ending December 31, 2024, with 49.29% growth.
Revenue
4.17M
Revenue Growth
+25.08%
P/S Ratio
5.11
Revenue / Employee
122.74K
Employees
34
Market Cap
21.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.17M | 836.81K | 25.08% |
| Dec 31, 2023 | 3.34M | -254.87K | -7.10% |
| Dec 31, 2022 | 3.59M | -1.15M | -24.27% |
| Dec 31, 2021 | 4.74M | 569.11K | 13.64% |
| Dec 31, 2020 | 4.17M | 665.26K | 18.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| Amplifon | 2.41B |
| DiaSorin | 1.21B |
| EL.En. | 580.41M |
| GPI S.p.A. | 531.42M |
| Svas Biosana | 134.95M |
| Talea Group | 132.17M |
| Farmacosmo | 59.23M |